Beigene Stock Price, News & Analysis
Company Description
Beigene (OTC Link: BEIGF) is a publicly traded biotechnology company in the Healthcare sector. The company has a market capitalization of $34.3B.
BEIGF stock has gained 15.2% over the past year. Shares last traded at $23.75.
On a trailing twelve-month basis, Beigene reported revenue of $5.3B with net income of $286.9M and diluted earnings per share of $0.19. The company operates at a net profit margin of 5.4%.
This page provides a comprehensive overview of BEIGF stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Beigene (BEIGF) stock last traded at $23.75. Over the past 12 months, the stock has gained 15.2%. At a market capitalization of $34.3B, BEIGF is classified as a large-cap stock with approximately 1.4B shares outstanding.
Latest News
SEC Filings
Beigene has filed 5 recent SEC filings, including 5 Form 4. The most recent filing was submitted on March 13, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all BEIGF SEC filings →
Financial Highlights
Beigene generated $5.3B in revenue over the trailing twelve months, retaining a 87.5% gross margin, operating income reached $447.1M (8.4% operating margin), and net income was $286.9M, reflecting a 5.4% net profit margin. Diluted earnings per share stood at $0.19. The company generated $1.1B in operating cash flow. With a current ratio of 3.41, the balance sheet reflects a strong liquidity position.
Upcoming Events
Short Interest History
Short interest in Beigene (BEIGF) currently stands at 71.8 thousand shares, up 266.0% from the previous reporting period, representing 0.0% of the float. Over the past 12 months, short interest has decreased by 69%. This relatively low short interest suggests limited bearish sentiment.
Days to Cover History
Days to cover for Beigene (BEIGF) currently stands at 1.0 days. This low days-to-cover ratio indicates high liquidity, allowing short sellers to quickly exit positions if needed. The days to cover has decreased 99.9% over the past year, suggesting improved liquidity for short covering. The ratio has shown significant volatility over the period, ranging from 1.0 to 1000.0 days.
BEIGF Company Profile & Sector Positioning
Beigene (BEIGF) operates in the Biotechnology industry within the broader Healthcare sector and is listed on the OTC Link.